Hospitals | December 19, 2025
Max Healthcare announces Rs.1,000-cr foray into Pune with 450-bed super speciality hospital
The state-of-the-art facility is expected to be commissioned over the next three years
The state-of-the-art facility is expected to be commissioned over the next three years
India plays a critical role in Bristol Myers Squibb’s global strategy
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
This launch is part of the company's strategy to expand its nutraceutical portfolio
Alphyn is developing Zabalafin Hydrogel as the first therapy to simultaneously tackle the interconnected drivers of AD
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
Subscribe To Our Newsletter & Stay Updated
